Erlotinib vs best supportive care as third-line treatment of advanced NSCLC: a real-world cost-effectiveness study.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Jun 2012 Results published in the Lung Cancer.
- 02 Aug 2011 New trial record
- 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.